S-Methyl 3-methylbutanethioate
Common Name: |
S-Methyl 3-methylbutanethioate |
IUPAC Name: |
S-methyl 3-methylbutanethioate |
Molecular Formula: |
C6H12OS |
SMILES: |
CC(C)CC(=O)SC |
Inchi: |
1S/C6H12OS/c1-5(2)4-6(7)8-3/h5H,4H2,1-3H3 |
Inchi Key: |
MPLWTJZAFOVXKP-UHFFFAOYSA-N |
Cas No: |
23747-45-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
132.22 |
Mass (g/mol) |
132.061 |
Molar Refractivity |
38.75 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
3 |
Rings |
|
TPSA |
42.37 |
Hetero Atoms |
2 |
Heavy Atoms |
8 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
157.00 to 158.00 |
Vapor Pressure (mmHg@25.00 °C) |
2.672 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.83 |
LogP |
1.922 |
iLOGP |
2.19 |
XLOGP3 |
1.92 |
WLOGP |
1.92 |
MLOGP |
1.39 |
ESOL Log S |
-1.67 |
ESOL Solubility (mg/ml) |
2.82 |
ESOL Solubility (mol/l) |
0.021 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.43 |
Ali Solubility (mg/ml) |
0.49 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.52 |
Silicos-IT Solubility (mg/ml) |
4 |
Silicos-IT Solubility (mol/l) |
0.03 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.74 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.615 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.18 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |